The present invention relates to a method of treating cancer by administering an IGF-1R specific antibody in combination with an anti-cancer agent exemplified by an Akt pathway inhibitor. The first and second amounts together comprise a therapeutically effective amount.本發明係關於一種藉由投與IGF-1R特異性抗體與Akt路徑抑制劑例示之抗癌劑組合治療癌症之方法。第一量與第二量一起包含治療有效量。(無元件符號說明)